AI Drug Design Market Trends and Forecast
The future of the global AI drug design market looks promising with opportunities in the cancer and cardiovascular disease markets. The global AI drug design market is expected to grow with a CAGR of 5.6% from 2024 to 2030. The major drivers for this market are increasing demand for personalized medicine, growing need for faster and more accurate drug design, and rise in AI capabilities enhances drug discovery efficiency.
• Lucintel forecasts that therapy research is expected to witness higher growth over the forecast period.
• Within this market, cancer is expected to witness the higher growth.
• APAC is expected to witness the highest growth over the forecast period.
Country Wise Outlook for the AI Drug Design Market
• United States: Companies like Insilico Medicine and Atomwise are pioneering AI-driven drug discovery, with initiatives focused on faster drug development cycles and precision medicine. The government is supporting these efforts through funding grants and regulatory frameworks to expedite approvals.
• China: In China, companies such as XtalPi and Infervision are making strides in AI-based drug design, aiming to enhance drug efficacy and reduce development costs. Government initiatives include funding for AI research in healthcare and collaborations between tech firms and pharmaceutical companies.
• United Kingdom: With companies like BenevolentAI and Healx leading the charge, the UK is leveraging AI to accelerate drug discovery for rare diseases and personalized therapies. Government-backed programs like the Accelerating Detection of Disease Initiative (ADDI) are driving innovation in this space.
• India: Indian companies like Innoplexus and Gennova Biopharmaceuticals are harnessing AI for drug discovery, focusing on affordable healthcare solutions and streamlined clinical trials. The governmentÄX%$%Xs initiatives include promoting AI startups in healthcare and establishing AI research hubs in collaboration with industry players.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
AI Drug Design Market by Segment
The study includes a forecast for the global AI drug design market by type, application, and region.
AI Drug Design Market by Type [Value from 2018 to 2030]:
• Therapy Research
• Design & Development
• Others
AI Drug Design Market by Application [Value from 2018 to 2030]:
• Cancer
• Cardiovascular Disease
• Others
AI Drug Design Market by Region [Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of AI Drug Design Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies AI drug design companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the AI drug design companies profiled in this report include-
• Exscientia
• PathAI
• Tempus
• Aria Pharmaceuticals
• BenchSci
• Antidote
• AiCure
• Atomwise
• Envisagenics
• Sherlock
Recent Development in the AI Drug Design Market
• Insilico Medicine: The company has developed AI-driven platforms that significantly reduce the time and cost of drug discovery. Their initiatives focus on using deep learning algorithms to analyze biological data and identify potential drug candidates with higher accuracy and efficiency.
• Atomwise: Atomwise utilizes AI technology to predict molecular interactions, enabling the rapid screening of potential drug compounds. Their recent announcement includes partnerships with several pharmaceutical companies to expedite the development of treatments for various diseases, including cancer and neurodegenerative disorders.
• BenevolentAI: This company specializes in using AI algorithms to analyze biomedical data and discover novel drug targets. Their initiative involves collaborations with academic institutions and pharmaceutical giants to identify promising drug candidates for clinical trials, particularly in areas with unmet medical needs such as rare diseases.
• XtalPi: XtalPi integrates AI, quantum mechanics, and cloud computing to optimize drug formulation and improve drug efficacy. Their recent development includes the launch of an AI-powered platform for drug solid-state research, aiming to enhance drug stability and bioavailability while reducing manufacturing costs.
• Healx: Healx focuses on using AI to accelerate drug repurposing for rare diseases, leveraging existing medications for new therapeutic purposes. Their key industry development includes securing funding for expanding their AI platformÄX%$%Xs capabilities and partnering with patient advocacy groups to prioritize treatments for underserved patient populations.
Features of the Global AI Drug Design Market
Market Size Estimates: AI drug design market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: AI drug design market size by type, application, and region in terms of value ($B).
Regional Analysis: AI drug design market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different types, applications, and regions for the AI drug design market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the AI drug design market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for AI drug design market?
Answer: The global AI drug design market is expected to grow with a CAGR of 5.6% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the AI drug design market?
Answer: The major drivers for this market are increasing demand for personalized medicine, growing need for faster and more accurate drug design, and rise in AI capabilities enhances drug discovery efficiency.
Q3. What are the major segments for AI drug design market?
Answer: The future of the AI drug design market looks promising with opportunities in the cancer and cardiovascular disease markets.
Q4. Who are the key AI drug design market companies?
Answer: Some of the key AI drug design companies are as follows:
• Exscientia
• PathAI
• Tempus
• Aria Pharmaceuticals
• BenchSci
• Antidote
• AiCure
• Atomwise
• Envisagenics
• Sherlock
Q5. Which AI drug design market segment will be the largest in future?
Answer: Lucintel forecasts that therapy research is expected to witness higher growth over the forecast period.
Q6. In AI drug design market, which region is expected to be the largest in next 5 years?
Answer: APAC is expected to witness the highest growth over the forecast period.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the AI drug design market by type (therapy research, design & development, and others), application (cancer, cardiovascular disease, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to AI Drug Design Market Market, AI Drug Design Market Market Size, AI Drug Design Market Market Growth, AI Drug Design Market Market Analysis, AI Drug Design Market Market Report, AI Drug Design Market Market Share, AI Drug Design Market Market Trends, AI Drug Design Market Market Forecast, AI Drug Design Market Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.